|
|
|
|
|
|
|
|
|
20.10.26 - 09:24
|
Nemetschek Aktie: S-K-S-Umkehr gewinnt an Konturen (Aktiencheck)
|
|
|
Düsseldorf (www.aktiencheck.de) - Nemetschek-Chartanalyse von HSBC Trinkaus & Burkhardt:
Die Analysten von HSBC Trinkaus & Burkhardt nehmen in einer aktuellen Aktienanalyse die Aktie der Nemetschek SE (ISIN: DE0006452907, WKN: 645290, Ticker-Symbol: NEM) charttechnisch unter die Lupe.
Der "HSBC Trendkompass" filtere Woche für Woche mehr als 100 Basiswerte nach den Kriterien Relative Stärke (Levy) und Momentum. [mehr]...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13.10.26 - 13:54
|
Here Are Tuesday′s Top Wall Street Analyst Research Calls: AT&T, Adobe, Albemarle, American Electric Power, Pershing Square, RTX, SoFi Technologies, Technip FMC, YETI Holdings, and More (24/7 Wall St.)
|
|
|
Pre-Market Stock Futures: Futures are trading mixed after a slow start to the week, ahead of the 3rd-quarter earnings season, which kicks off today with four large-cap financial stocks reporting, and for the first time in a long time, JPMorgan Chase & Company (NYSE: JPM) missed earnings expectations. The major indices closed mixed on Monday, […]...
|
|
|
|
|
|
|
09.10.26 - 00:42
|
H.B. Fuller Announces Pricing of $850 Million Debt Offering (Business Wire)
|
|
|
ST. PAUL, Minn.--(BUSINESS WIRE)--H.B. Fuller Company (“H.B. Fuller”) (NYSE:FUL) announced today that it has priced an offering of $850 million aggregate principal amount of 7.625% new senior unsecured notes due 2034 (the “Notes”) at an issue price of 100% of the principal amount, in a private offering (the “Notes Offering”) that is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”).
The issuance of the Notes is expected to close on or about October 21, 2026, subject to customary closing conditions. The Notes will pay interest on a semi-annual basis.
H.B. Fuller intends to use the net proceeds from the Notes Offering, together with other available cash and borrowings, to fund the purchase price for the acquisition (the “Acquisition”) of Advanced Medical Solutions Group plc (“AMS”), to repay other borrowings under its Second Amended and Restated Credit Agreement, dated as of February 15, 2023, as amended, and to fund the repaym...
|
|
|
|